{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T03:02:07Z","timestamp":1791774127526,"version":"4.3.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Biology and Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.compbiolchem.2024.108249","type":"journal-article","created":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T06:23:15Z","timestamp":1728714195000},"page":"108249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["E-pharmacophore based virtual screening of potent lead molecules against Cystic Fibrosis: An in silico study"],"prefix":"10.1016","volume":"113","author":[{"given":"Sabareeswari","family":"Jeyaraman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1116-6580","authenticated-orcid":false,"given":"Jeyanthi","family":"Sankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling Shing","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7755-3381","authenticated-orcid":false,"given":"Karthikeyan","family":"Muthusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiolchem.2024.108249_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2016.12.010","article-title":"Molecular modeling, simulation and docking study of ebola virus glycoprotein","volume":"72","author":"Ahmad","year":"2017","journal-title":"J. Mol. Graph. Model."},{"issue":"2","key":"10.1016\/j.compbiolchem.2024.108249_bib2","article-title":"Glide docking, autodock, binding free energy and drug-likeness studies for prediction of potential inhibitors of cyclin-dependent kinase 14 protein in wnt signaling pathway","volume":"12","author":"Bathula","year":"2021","journal-title":"Biointerface Res Appl. Chem."},{"issue":"1","key":"10.1016\/j.compbiolchem.2024.108249_bib3","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-016-2393-9","article-title":"Cystic fibrosis: a clinical view","volume":"74","author":"Castellani","year":"2017","journal-title":"Cell. Mol. life Sci."},{"issue":"3","key":"10.1016\/j.compbiolchem.2024.108249_bib4","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ame2.12180","article-title":"A review of cystic fibrosis: basic and clinical aspects","volume":"4","author":"Chen","year":"2021","journal-title":"Anim. Models Exp. Med."},{"issue":"6","key":"10.1016\/j.compbiolchem.2024.108249_bib5","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3390\/molecules29061232","article-title":"Identification of potent acetylcholinesterase inhibitors as new candidates for alzheimer disease via virtual screening, molecular docking, dynamic simulation, and molecular mechanics\u2013poisson\u2013boltzmann surface area calculations","volume":"29","author":"Chennai","year":"2024","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.compbiolchem.2024.108249_bib6","doi-asserted-by":"crossref","DOI":"10.1080\/07391102.2014.963146","article-title":"Identification of potent inhibitors against snake venom metalloproteinase (SVMP) using molecular docking and molecular dynamics studies","volume":"33","author":"Chinnasamy","year":"2015","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"12","key":"10.1016\/j.compbiolchem.2024.108249_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/thoraxjnl-2013-203204","article-title":"Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications","volume":"68","author":"Cohen-Cymberknoh","year":"2013","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.compbiolchem.2024.108249_bib8","article-title":"Cystic fibrosis in the year 2020: a disease with a new face","volume":"109","author":"De Boeck","year":"2020","journal-title":"Actapaediatrica"},{"key":"10.1016\/j.compbiolchem.2024.108249_bib9","doi-asserted-by":"crossref","DOI":"10.1007\/s13337-016-0356-2","article-title":"Potential entry inhibitors of the envelope protein (E2) of Chikungunya virus: in silico structural modeling, docking and molecular dynamic studies","volume":"28","author":"Deeba","year":"2017","journal-title":"VirusDisease"},{"key":"10.1016\/j.compbiolchem.2024.108249_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gku401","article-title":"ProTox: a web server for the in silico prediction of rodent oral toxicity","volume":"42","author":"Drwal","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.compbiolchem.2024.108249_bib11","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20212006","article-title":"Molecular mechanisms of cystic fibrosis\u2013how mutations lead to misfunction and guide therapy","volume":"42","author":"Farinha","year":"2022","journal-title":"Biosci. Rep."},{"issue":"7","key":"10.1016\/j.compbiolchem.2024.108249_bib12","doi-asserted-by":"crossref","DOI":"10.1080\/07391102.2018.1464958","article-title":"In silico identification and screening of CYP24A1 inhibitors: 3D QSAR pharmacophore mapping and molecular dynamics analysis","volume":"37","author":"Jayaraj","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"11","key":"10.1016\/j.compbiolchem.2024.108249_bib13","doi-asserted-by":"crossref","DOI":"10.1080\/07391102.2020.1775122","article-title":"Structural insights on Vitamin D receptor and screening of new potent agonist molecules: structure and ligand-based approach","volume":"39","author":"Jayaraj","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"11","key":"10.1016\/j.compbiolchem.2024.108249_bib14","doi-asserted-by":"crossref","DOI":"10.1513\/AnnalsATS.201701-058OC","article-title":"An observational study of outcomes and tolerances in patients with cystic fibrosis initiated on lumacaftor\/ivacaftor","volume":"14","author":"Jennings","year":"2017","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.compbiolchem.2024.108249_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkh468","article-title":"Protein structure prediction and analysis using the Robetta server","volume":"32","author":"Kim","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiolchem.2024.108249_bib16","doi-asserted-by":"crossref","DOI":"10.1007\/s00044-011-9719-9","article-title":"Homology modeling, molecular dynamics, and molecular docking studies of Trichomonasvaginaliscarbamate kinase","volume":"21","author":"Kirubakaran","year":"2012","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.compbiolchem.2024.108249_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2019.04.023","article-title":"E-pharmacophore modelling, virtual screening, molecular dynamics simulations and in-silico ADME analysis for identification of potential E6 inhibitors against cervical cancer","volume":"1189","author":"Kumar","year":"2019","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.compbiolchem.2024.108249_bib18","first-page":"1","article-title":"Theoretical investigation on known renin inhibitors and generation of ligand-based pharmacophore models for hypertension treatment","author":"Loganathan","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"3","key":"10.1016\/j.compbiolchem.2024.108249_bib19","doi-asserted-by":"crossref","DOI":"10.1021\/jp505332p","article-title":"Automatic GROMACS topology generation and comparisons of force fields for solvation free energy calculations","volume":"119","author":"Lundborg","year":"2015","journal-title":"J. Phys. Chem. B"},{"issue":"4","key":"10.1016\/j.compbiolchem.2024.108249_bib20","doi-asserted-by":"crossref","DOI":"10.1080\/10799893.2019.1660895","article-title":"High-throughput virtual screening, ADME analysis, and estimation of MM\/GBSA binding-free energies of azoles as potential inhibitors of Mycobacterium tuberculosis H37Rv","volume":"39","author":"Madhavaram","year":"2019","journal-title":"J. Recept. Signal Transduct."},{"key":"10.1016\/j.compbiolchem.2024.108249_bib21","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"MadhaviSastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"12","key":"10.1016\/j.compbiolchem.2024.108249_bib22","doi-asserted-by":"crossref","DOI":"10.1021\/ct200196m","article-title":"An automated force field topology builder (ATB) and repository: version 1.0","volume":"7","author":"Malde","year":"2011","journal-title":"J. Chem. Theory Comput."},{"issue":"4","key":"10.1016\/j.compbiolchem.2024.108249_bib23","article-title":"Homology modeling, virtual screening, prime-MMGBSA, AutoDock-identification of inhibitors of FGR protein","volume":"11","author":"Muddagoni","year":"2021","journal-title":"Biointerface Res. Appl. Chem."},{"key":"10.1016\/j.compbiolchem.2024.108249_bib24","doi-asserted-by":"crossref","DOI":"10.1007\/s11892-014-0511-3","article-title":"Cystic fibrosis related diabetes","volume":"14","author":"O\u2019Shea","year":"2014","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.compbiolchem.2024.108249_bib25","article-title":"Molecular dynamics simulation study on the structural instability of the most common cystic fibrosis-associated mutant \u0394F508-CFTR","volume":"15","author":"Odera","year":"2018","journal-title":"Biophys. Phys."},{"issue":"6","key":"10.1016\/j.compbiolchem.2024.108249_bib26","article-title":"In-silico analysis and molecular dynamics simulations of lysozyme by GROMACS 2020.2","volume":"25","author":"Panwar","year":"2021","journal-title":"Ann. Rom. Soc. Cell Biol."},{"key":"10.1016\/j.compbiolchem.2024.108249_bib27","doi-asserted-by":"crossref","DOI":"10.5530\/ctbp.2020.4.48","article-title":"Cystic fibrosis in human-a review","volume":"14","author":"Patel","year":"2020","journal-title":"Curr. TRENDS Biotechnol. Pharm."},{"issue":"04","key":"10.1016\/j.compbiolchem.2024.108249_bib28","doi-asserted-by":"crossref","DOI":"10.1142\/S0219633619500214","article-title":"E-pharmacophore hypothesis strategy to discover potent inhibitor for influenza treatment","volume":"18","author":"Rohini","year":"2019","journal-title":"J. Theor. Comput. Chem."},{"issue":"1","key":"10.1016\/j.compbiolchem.2024.108249_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.sjbs.2020.10.023","article-title":"In-silico protein-ligand docking studies against the estrogen protein of breast cancer using pharmacophore based virtual screening approaches","volume":"28","author":"Sahayarayan","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.compbiolchem.2024.108249_bib30","doi-asserted-by":"crossref","DOI":"10.1007\/s00894-011-1018-3","article-title":"Homology modeling, molecular dynamics, e-pharmacophore mapping and docking study of Chikungunya virus nsP2 protease","volume":"18","author":"Singh","year":"2012","journal-title":"J. Mol. Model."},{"issue":"2","key":"10.1016\/j.compbiolchem.2024.108249_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.prrv.2010.01.003","article-title":"Fertility in men with cystic fibrosis assessment, investigations and management","volume":"11","author":"Smith","year":"2010","journal-title":"Paediatr. Respir. Rev."},{"key":"10.1016\/j.compbiolchem.2024.108249_bib32","article-title":"Structure based pharmacophore modelling approach for the design of azaindole derivatives as DprE1 inhibitors for tuberculosis","volume":"101","author":"Suma","year":"2020","journal-title":"J. Mol. Graph. Model."},{"issue":"11","key":"10.1016\/j.compbiolchem.2024.108249_bib33","doi-asserted-by":"crossref","DOI":"10.1080\/14740338.2017.1372419","article-title":"The safety of lumacaftor and ivacaftor for the treatment of cystic fibrosis","volume":"16","author":"Talamo Guevara","year":"2017","journal-title":"Expert Opin. Drug Saf."},{"issue":"1","key":"10.1016\/j.compbiolchem.2024.108249_bib34","article-title":"The pancreas in cystic fibrosis","volume":"3","author":"Taylor","year":"2002","journal-title":"Paediatr. Respir. Rev."},{"issue":"1","key":"10.1016\/j.compbiolchem.2024.108249_bib35","doi-asserted-by":"crossref","DOI":"10.1080\/07391102.2017.1420489","article-title":"Molecular docking, QSAR and ADMET based mining of natural compounds against prime targets of HIV","volume":"37","author":"Vora","year":"2019","journal-title":"J. Biomol. Struct. Dyn."}],"container-title":["Computational Biology and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927124002378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927124002378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T15:04:40Z","timestamp":1734015880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476927124002378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":35,"alternative-id":["S1476927124002378"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2024.108249","relation":{},"ISSN":["1476-9271"],"issn-type":[{"value":"1476-9271","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"E-pharmacophore based virtual screening of potent lead molecules against Cystic Fibrosis: An in silico study","name":"articletitle","label":"Article Title"},{"value":"Computational Biology and Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2024.108249","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108249"}}